Whanin forms partnership with Abbott Korea

Published: 2013-08-14 06:58:00

Updated: 2013-08-14 06:58:00

Whanin Pharm announced on last Thursday that it has entered into a partnership agreement with Abbott Korea for the marketing and distribution of the latter’s Depakote (divalproex sodium) from next month in Korea.

With diverse formulations (e.g. tablets, extended release form, capsule and injec...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK